4-butyrolactone has been researched along with Epilepsy, Absence in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 7 (35.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arcaro, JA; Leung, LS; Mirsattari, SM; Mousavi, SR; Tenney, JR | 1 |
| Chen, CC; Cheong, E; Choi, EJ; Latchoumane, C; Lee, B; Lee, CJ; Lee, J; Lee, SE; Oh, SJ; Park, C; Saud, ZA; Shin, HS; Sun, N | 1 |
| Bonifácio, MJ; Pires, NM; Soares-da-Silva, P | 1 |
| Arcaro, J; Chu, L; Kuo, M; Ma, J; Mirsattari, SM; Stan Leung, L | 1 |
| Ahmed, M; Burnham, WM; Chan, KF; Chieverton, L; Liu, RR; Scott, BW; Wong, G; Wood, J | 1 |
| Cheong, E; Choi, JH; Lee, CJ; Lee, K; Park, C; Paydar, A; Shin, HS; Zaman, T | 1 |
| Kato, S; Koriyama, Y; Liu, Z; Matsukawa, T; Takizawa, N; Tanaka, M | 1 |
| Ferris, CF; King, JA; Marshall, PC; Tenney, JR | 1 |
| Kang, UB; Kim, D; Kim, J; Lee, C; Ryu, MJ; Shin, HS; Yu, MH | 1 |
| Dominguez, LG; Huo, JZ; Leshchenko, Y; Snead, OC; Velazquez, JL | 1 |
| Covey, DF; Ferrendelli, JA; Klunk, WE; McKeon, A | 1 |
| Snead, OC | 2 |
| Baba, H; Ono, K; Sugai, S | 1 |
| Aizawa, M; Fukuda, H; Ito, Y | 1 |
| Fukuda, H; Ishige, K; Ito, Y | 1 |
| Banerjee, PK; Brailowsky, S; Olsen, RW; Snead, OC; Tillakaratne, NJ; Tobin, AJ | 1 |
| Banerjee, PK; Hu, RQ; Snead, OC | 1 |
| Jeong, MJ; Keum, S; Kim, D; Kim, SS; Lee, T; McEnery, MW; Shin, HS; Song, I | 1 |
| Bernasconi, R; Bittiger, H; Lauber, J; Leonhardt, T; Marescaux, C; Martin, P; Reymann, N; Rubio, V; Vergnes, M | 1 |
20 other study(ies) available for 4-butyrolactone and Epilepsy, Absence
| Article | Year |
|---|---|
Functional connectivity of the hippocampus to the thalamocortical circuitry in an animal model of absence seizures.
Topics: 4-Butyrolactone; Animals; Cerebral Cortex; Cerebrovascular Circulation; Disease Models, Animal; Epilepsy, Absence; Functional Laterality; Hippocampus; Male; Neural Pathways; Oxygen; Rats, Sprague-Dawley; Rest; Thalamus; Time Factors | 2017 |
Rebound burst firing in the reticular thalamus is not essential for pharmacological absence seizures in mice.
Topics: 4-Butyrolactone; Action Potentials; Animals; Calcium Channels, T-Type; Disease Models, Animal; Electrophysiological Phenomena; Epilepsy, Absence; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Patch-Clamp Techniques; Thalamic Nuclei | 2014 |
Carbamazepine aggravates absence seizures in two dedicated mouse models.
Topics: 4-Butyrolactone; Animals; Anticonvulsants; Calcium Channels, T-Type; Carbamazepine; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy, Absence; Ethosuximide; Male; Mice; Mice, Inbred Strains; Motor Activity; Patch-Clamp Techniques; Psychomotor Performance; Receptors, GABA-A | 2015 |
The hippocampus participates in a pharmacological rat model of absence seizures.
Topics: 4-Butyrolactone; Animals; Cerebral Cortex; Cortical Synchronization; Disease Models, Animal; Electrodes, Implanted; Epilepsy, Absence; GABA-A Receptor Agonists; Hippocampus; Male; Muscimol; Neural Pathways; Neurons; Rats, Long-Evans; Receptors, GABA-A; Seizures; Thalamus; Theta Rhythm | 2016 |
Cytogenesis in the adult rat dentate gyrus is increased following kindled seizures but is unaltered in pharmacological models of absence seizures.
Topics: 4-Butyrolactone; Animals; Animals, Newborn; Anticholesteremic Agents; Bromodeoxyuridine; Cell Count; Dentate Gyrus; Disease Models, Animal; Electroencephalography; Epilepsy, Absence; Gene Expression Regulation; Kindling, Neurologic; Male; Nerve Tissue Proteins; Neurogenesis; Rats; Rats, Long-Evans; trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride | 2010 |
Cav2.3 channels are critical for oscillatory burst discharges in the reticular thalamus and absence epilepsy.
Topics: 4-Butyrolactone; Action Potentials; Animals; Calcium Channels, R-Type; Cation Transport Proteins; Electroencephalography; Epilepsy, Absence; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Reticular Formation; Thalamic Nuclei | 2011 |
A dissociation of gamma-butyrolactone-induced absence seizure and CRE- and AP-1 DNA-binding activities in the developing rat brain.
Topics: 4-Butyrolactone; Age Factors; Animals; Binding, Competitive; Brain; Cyclic AMP Response Element-Binding Protein; Electroencephalography; Epilepsy, Absence; Male; Rats; Rats, Sprague-Dawley; Transcription Factor AP-1 | 2003 |
fMRI of generalized absence status epilepticus in conscious marmoset monkeys reveals corticothalamic activation.
Topics: 4-Butyrolactone; Animals; Brain; Callithrix; Cerebral Cortex; Consciousness; Disease Models, Animal; Epilepsy, Absence; Magnetic Resonance Imaging; Male; Neural Pathways; Oxygen; Status Epilepticus; Thalamus | 2004 |
Proteomic analysis of gamma-butyrolactone-treated mouse thalamus reveals dysregulated proteins upon absence seizure.
Topics: 4-Butyrolactone; Animals; Calcium-Binding Proteins; Convulsants; Cytoskeletal Proteins; Down-Regulation; Electrophoresis, Gel, Two-Dimensional; Epilepsy, Absence; Male; Mice; Nerve Tissue Proteins; Neurons; Neurotransmitter Agents; Presynaptic Terminals; Proteomics; Thalamus; Time Factors | 2007 |
Typical versus atypical absence seizures: network mechanisms of the spread of paroxysms.
Topics: 4-Butyrolactone; Action Potentials; Animals; Cerebral Cortex; Cortical Spreading Depression; Cortical Synchronization; Disease Models, Animal; Electrodes, Implanted; Electroencephalography; Epilepsy, Absence; Hippocampus; Models, Neurological; Neural Inhibition; Neural Pathways; Rats; Rats, Long-Evans; Recruitment, Neurophysiological; Synaptic Transmission; Thalamus; trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride | 2007 |
Alpha-substituted gamma-butyrolactones: new class of anticonvulsant drugs.
Topics: 4-Butyrolactone; Animals; Anticonvulsants; Chemical Phenomena; Chemistry; Convulsants; Drug Evaluation, Preclinical; Electroencephalography; Epilepsy, Absence; Ethosuximide; Furans; Guinea Pigs; Mice; Structure-Activity Relationship; Trimethadione | 1982 |
The ontogeny of [3H]gamma-hydroxybutyrate and [3H]GABAB binding sites: relation to the development of experimental absence seizures.
Topics: 4-Butyrolactone; Animals; Animals, Newborn; Binding Sites; Electrophysiology; Epilepsy, Absence; gamma-Aminobutyric Acid; Rats; Rats, Sprague-Dawley; Sodium Oxybate; Tritium | 1994 |
A new chronic model of spontaneous nonconvulsive generalized seizures.
Topics: 4-Butyrolactone; Animals; Cerebral Cortex; Corpus Callosum; Electroencephalography; Epilepsy, Absence; Epilepsy, Generalized; Ethosuximide; Evoked Potentials; Injections, Intraperitoneal; Male; Phenytoin; Rats; Rats, Wistar; Seizures; Sodium Oxybate; Valproic Acid | 1993 |
Roles of gamma-aminobutyric acidB (GABA B) and gamma-hydroxybutyric acid receptors in hippocampal long-term potentiation and pathogenesis of absence seizures.
Topics: 4-Butyrolactone; Animals; Anticonvulsants; Baclofen; Benzocycloheptenes; Electroencephalography; Epilepsy, Absence; Female; GABA Agonists; GABA Modulators; Hippocampus; Long-Term Potentiation; Male; Mice; Receptors, Cell Surface; Receptors, GABA-B | 1997 |
Pharmacological profiles of absence seizure-induced increases in CRE- and AP-1 DNA-binding activities in gamma-butyrolactone-treated mice.
Topics: 4-Butyrolactone; Activating Transcription Factor 2; Animals; Anticonvulsants; Brain; Brain Chemistry; Cerebral Cortex; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; DNA-Binding Proteins; Epilepsy, Absence; Ethosuximide; GABA Antagonists; Mice; Organophosphorus Compounds; Phosphinic Acids; Thalamus; Transcription Factor AP-1; Transcription Factors | 1998 |
Alterations in GABAA receptor alpha 1 and alpha 4 subunit mRNA levels in thalamic relay nuclei following absence-like seizures in rats.
Topics: 4-Butyrolactone; Animals; Epilepsy, Absence; GABA Antagonists; GABA Modulators; Gene Expression; Hippocampus; In Situ Hybridization; Male; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; RNA, Messenger; Thalamus; Time Factors | 1998 |
Regulation of gamma-aminobutyric acid (GABA) release in cerebral cortex in the gamma-hydroxybutyric acid (GHB) model of absence seizures in rat.
Topics: 4-Butyrolactone; Animals; Cerebral Cortex; Electroencephalography; Epilepsy, Absence; GABA Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Hydroxybutyrates; Male; Microdialysis; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptors, GABA-B; Solvents; Thalamus | 2000 |
Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking alpha(1G) T-type Ca(2+) channels.
Topics: 4-Butyrolactone; Animals; Baclofen; Calcium Channels, T-Type; Cerebral Cortex; Electroencephalography; Epilepsy, Absence; Immunity, Innate; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Protein Subunits; Receptors, GABA-B; Seizures; Thalamic Nuclei; Thalamus | 2001 |
Evidence for G protein modulation of experimental-generalized absence seizures in rat.
Topics: 4-Butyrolactone; Animals; Cerebral Ventricles; Electroencephalography; Epilepsy, Absence; GTP-Binding Proteins; Injections, Intraventricular; Male; Pentylenetetrazole; Pertussis Toxin; Rats; Rats, Sprague-Dawley; Time Factors; Virulence Factors, Bordetella | 1992 |
Experimental absence seizures: potential role of gamma-hydroxybutyric acid and GABAB receptors.
Topics: 4-Butyrolactone; Animals; Baclofen; Brain; Cyclic GMP; Disease Models, Animal; Epilepsy, Absence; GABA-A Receptor Antagonists; Male; Organophosphorus Compounds; Rats; Rats, Inbred Strains; Receptors, GABA-A; Reference Values; Reproducibility of Results; Sodium Oxybate; Valproic Acid | 1992 |